SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen
2013 ◽
Vol 56
(11)
◽
pp. 1637-1645
◽
2012 ◽
Vol 12
(1)
◽
pp. 27-35
◽
2007 ◽
Vol 45
(4)
◽
pp. 401-410
◽
2009 ◽
Vol 64
(1)
◽
pp. 118-125
◽
Keyword(s):
Keyword(s):
1991 ◽
Vol 32
(16)
◽
pp. 1897-1898
◽
Keyword(s):